DOI:
10.1055/s-00000072
Seminars in Reproductive Medicine
LinksClose Window
References
Gorcea CM, Burthem J, Tholouli E.
ASP2215 in the treatment of relapsed/refractory acute myeloid leukemia with FLT3 mutation: background and design of the ADMIRAL trial.
Future Oncol 2018;
14 (20) 1995-2004
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.